Genetic polymorphism of CYP2D6 in Korean population.

被引：0
作者：
Jung, HJ
Kim, MK
Yoon, YR
Park, JY
Shin, JG
机构：
[1] Inje Univ, Coll Med, Dept Pharmacol, Pusan, South Korea
[2] Pusan Paik Hosp, Clin Pharmacol Ctr, Pusan, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2001年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P38 / P38
页数：1
相关论文
共 50 条
  • [21] Genetic polymorphism of CYP2D6 and lung cancer risk
    Shaw, GL
    Falk, RT
    Frame, JN
    Weiffenbach, B
    Nesbitt, JC
    Pass, HI
    Caporaso, NE
    Moir, DT
    Tucker, MA
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1998, 7 (03) : 215 - 219
  • [22] Genetic polymorphism of CYP2D6 in Chinese subjects in Malaysia
    Ismail, R
    Teh, LK
    Amir, J
    Alwi, Z
    Lopez, CG
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2003, 28 (04) : 279 - 284
  • [23] Effects of CYP2D6 genetic polymorphism on the pharmacokinetics of metoclopramide
    Jung-Woo Bae
    Kyung-Yul Oh
    So-Jung Yoon
    Hyo-Bin Shin
    Eui Hyun Jung
    Chang-Keun Cho
    Chang Woo Lim
    Pureum Kang
    Chang-Ik Choi
    Choon-Gon Jang
    Seok-Yong Lee
    Yun Jeong Lee
    Archives of Pharmacal Research, 2020, 43 : 1207 - 1213
  • [24] Genetic polymorphism of CYP2D6 in North Indian subjects
    Lamba, V
    Lamba, JK
    Dilawari, JB
    Kohli, KK
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (9-10) : 787 - 791
  • [25] Genetic polymorphism of CYP2D6: Malaysian Indians have the highest frequency for CYP2D6*4 in Asia
    Rusli Ismail
    L. Teh
    European Journal of Clinical Pharmacology, 2001, 57 : 617 - 618
  • [26] Effect of CYP2D6 genetic polymorphism on peak propafenone concentration: no significant effect of CYP2D6*10
    Doki, Kosuke
    Shirayama, Yuki
    Sekiguchi, Yukio
    Aonuma, Kazutaka
    Kohda, Yukinao
    Ieda, Masaki
    Homma, Masato
    PHARMACOGENOMICS, 2020, 21 (18) : 1279 - 1288
  • [27] Genetic polymorphism of CYP2D6 in North Indian subjects
    V. Lamba
    J. K. Lamba
    J. B. Dilawari
    K. K. Kohli
    European Journal of Clinical Pharmacology, 1998, 54 : 787 - 791
  • [28] CYP2D6 genetic polymorphism in south Indian populations
    Theophilus, Naveen Amrithraj
    Chandrasekaran, Adithan
    Sam, Soya Sisy
    Gerard, Nathalie
    Rajagopal, Kpishnamoorthy
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2006, 29 (08) : 1655 - 1658
  • [29] Genetic polymorphism of CYP2D6:: Malaysian Indians have the highest frequency for CYP2D6*4 in Asia
    Ismail, R
    Teh, LK
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 57 (08) : 617 - 618
  • [30] Population pharmacokinetic analysis of tramadol and O-desmethyltramadol with genetic polymorphism of CYP2D6
    Lee, Joomi
    Yoo, Hee-Doo
    Bae, Jung-Woo
    Lee, Sooyeun
    Shin, Kwang-Hee
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 1751 - 1761
12345